Article

Cross-state variation in opioid use disorder among a privately insured nonelderly population in the United States

2020-06-12

Abstract excerpt

<h4>Background</h4> Although cross-state variation of the opioid epidemic in the United States are well documented in general, little are known about the epidemic in privately insured individuals. <h4>Objectives</h4> To describe cross-state variation in Opioid Use Disorder (OUD) among privately insured individuals in the US for the years 2005-2015 and investigate demographic differences of OUD patients between a g...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4acbf09e-63e0-55e3-a928-533f5ea8490d
DOI: 10.1101/2020.06.09.20121269

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cross-state variation in opioid use disorder among a privately insured nonelderly population in the United StatesDOI 10.1101/2020.06.09.20121269Read

Pronounced State Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019-2020)Semantic proximity Read

National Increase but Pronounced Regional Disparities in Naloxone Prescribing to United States Medicaid and Medicare PatientsSemantic proximity Read

Association of opioid use disorder with healthcare utilization and cost in a public health systemSemantic proximity Read

Identifying high-risk comorbidities of short and long-term opioid prescription useSemantic proximity Read

Disparities in Naltrexone Prescriptions to Medicaid Enrollees During the COVID-19 PandemicSemantic proximity Read

Analysis of State-level Variation in Distribution of Oxycodone and its Adverse Effect Profile in the US from 2000-2021Semantic proximity Read

Investigation of Opioid Use Disorder and Its Relevant Risk Factors—A Cross-Sectional Survey in Hospitalized Medically Ill PatientsSemantic proximity Read

Does Medicaid Institutions for Mental Diseases Exclusion Waiver Crowd Out the Access to Treatment Among Commercially Insured Substance Use Disorder Patients? An Empirical Study Using Commercial Insurance Claims DataSemantic proximity Read

Outcomes of Patients with COVID-19 in the Setting of Chronic Opioid Use DisorderSemantic proximity Read

Overdose mortality rates for opioids or stimulants are higher in males than females, controlling for rates of drug misuse: State-level dataSemantic proximity Read

Experiences of Opioid Use and Perceptions of Medication-Assisted Treatment (MAT) in Oakland's Safety Net Clinics Amid the COVID-19 PandemicSemantic proximity Read

Epidemiology of chronic pain and opioid use in primary care – a scoping review of big data researchSemantic proximity Read